Search results
Showing 3286 to 3300 of 8905 results
People and communities - putting you at the heart of our work
NICE is committed to involving people who use services, carers and the public in the development of our guidance and other products.
Find out more about the NICE technology appraisal advisory committee B members and their registered interests
Biographies and registered interests for members of the Technology Appraisal Committee A
A timeline showing where in the NICE evaluation process companies will be charged.
Decision aid for Intrabeam radiotherapy system for adjuvant treatment of early breast cancer, TA501 c NICE 2018. All rights reserved. Subject to...
Mapping NICE guidelines to the CQC's single assessment framework
This NICE resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
Referral points to virtual wards are similar to traditional models of care. Our guidance and advice can help you decide where to provide care and what to consider.
We're working with colleagues to ensure that virtual wards are used in a way that maximises the value for patients and the NHS.
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
In virtual wards, patients remain at home to receive hospital-level care. Our guidance can help you determine if patients are suitable for admission to the virtual wards system.
Check our list of appointed suppliers to find out which knowledge resources and services they can offer.
Access to a range of journals, databases and other evidence-based resources for health and social care staff in England.
A guide to the steps to follow when buying sole supplied titles from Lot 1 of our purchasing framework.
Sole supplied titles are distinct journal and book collections that can be purchased from Lot 1 of our purchasing framework.
Managed access allows people to access promising new treatments that would otherwise not be recommended because it is too uncertain whether the treatment is cost-effective.